Scandion Oncology welcomes Mads Aaboe Jensen as VP for Business Development and Innovation

Scandion Oncology announces the appointment of Mads Aaboe Jensen, PhD as VP for Business Development and Innovation.

Mads brings to Scandion Oncology over 20 years of cancer biology experience and about 8 years of experience from the life science industry. He has previously worked with various aspects of business development, search and evaluation and R&D in biotech and pharma.

He spent the last 7 years at Roche, where he held positions of increasing responsibilities and worked with strategic R&D partnerships. Mads joins Scandion Oncology from a position as External Innovation Officer for the therapeutic modality research division within the Roche Pharma Research & Early Development organization. He has liaised with Roche Partnering on assessment and evaluation of external opportunities e.g., related to RNA-based pharmaceuticals across multiple disease areas. Prior to this, he worked for Santaris Pharma A/S as a project manager for drug discovery projects with external pharmaceutical companies and spent 7 years at Cold Spring Harbor Laboratories. Mads joins the leadership team of Scandion Oncology to work with them on business development, positioning and strategic innovation of the pipeline according to the company strategy.